Attitudes towards glaucoma genetic risk assessment in unaffected individuals
Georgina L. HollittiD, Owen M. SiggsiD, Bronwyn Ridge, Miriam C. KeaneiD, David Anthony MackeyiD, Stuart MacGregoriD, Alex William HewittiD, Jamie E. CraigiD, Emmanuelle SouzeauiD
Abstract
Integrating polygenic risk scores (PRS) into healthcare has the potential to stratify an individuals risk of glaucoma across a broad population. Glaucoma is the most common cause of irreversible blindness worldwide, therefore effective screening for glaucoma endorsed by the population is highly important. This study assessed the attitude of unaffected individuals towards PRS testing for glaucoma, and sought to identify factors associated with interest in testing. We surveyed 418 unaffected individuals including those with a first-degree relative with glaucoma (n=193), those who had a recent eye examination (n=117), and general members of the community (n=108). Overall, 71.3% indicated an interest in taking a polygenic risk test for glaucoma. Interest was more likely in those who believed glaucoma to be a severe medical condition (OR 14.58, 95%CI (1.15-185.50), p=0.039), those concerned about developing glaucoma (OR 4.37, 95%CI (2.32-8.25), p<0.001), those with an intention to take appropriate measures regarding eye health (OR 2.39, 95%CI (1.16-4.95), p=0.019), and those preferring to know if considered to be at-risk or not (OR 4.52, 95%CI (2.32-8.83), p<0.001). These findings represent a valuable assessment of general public interest in glaucoma polygenic risk testing, which will be integral to the implementation and uptake of novel PRS based tests into clinical practice.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 11
- FWCI
- 1.79
- Field percentile
- top 17%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Development and evaluation of patient-centred polygenic risk score reports for glaucoma screening
Georgina L. Hollitt, Mark Hassall, … Emmanuelle Souzeau·BMC Medical GenomicsPeer-reviewed·Jan 30, 2025
- Short-term psychosocial outcomes following disclosure of glaucoma polygenic risk score (INSiGHT Study)
Giorgina Maxwell, Robert Allen, … Emmanuelle Souzeau·medRxiv·Jul 1, 2026
- Step change in glaucoma polygenic risk score performance enables clinical utility and disease prediction across all major ancestries
Stuart MacGregor, Guiyan Ni, … Jamie E. Craig·medRxiv·Jan 24, 2026
- Endophenotype-Informed Polygenic Risk Stratification for Primary Open-Angle Glaucoma in individuals of African Ancestry
Aude Benigne Ikuzwe Sindikubwabo, Lannawill Caruth, … Shefali Setia-Verma·medRxiv·Sep 29, 2025
- Integrating Glaucoma Endophenotypes Improves Polygenic Risk Prediction for Primary Open-Angle Glaucoma Across Ancestries
Xiaoyi Gao·medRxiv·Mar 27, 2025
- Understanding Patient Perceptions of Genetic Testing to Predict Type 2 Diabetes Risk After Gestational Diabetes
Ria Patel, Martha Christodoulou, … Julia Zöllner·Endocrinology Diabetes & MetabolismPeer-reviewed·Mar 27, 2026